BJUI Mini Reviews - Intravesical Gemcitabine for Superficial Bladder Cancer: Rationale for a New Treatment Option
The present overview will address the rationale and the initial results of intravesical gemcitabine as a novel chemotherapeutic agent for SBC.
|
UroToday, 1802 Fifth Street, Berkeley CA 94710 510.540.0930 (fax), info@urotoday.com ISSN 1939-4810
Privacy Policy | © 2009 UroToday ® All Rights Reserved |
